logo
15:56 Mar 06

Venus Remedies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
704.85
+4.25 (+0.61%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Venus Remedies Ltd. Financials

Venus Remedies Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
704.85
+4.25 (+0.61%)
15:56 Mar 06
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

60/100
Affordable Valuation

Technical

53/100
Technically Neutral

Strength

16

Weakness

2

Opportunity

1

Threats

0

8.07 %

ROE %

6.33 %

ROA %

57.09

EPS

419.65

BVPS

6.99 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
548.12 598.65 555.51 601.45 647.89
Operating Expenses +
494.34 536.54 495.31 541.86 584.35
Raw Material
347.94 381.97 322.95 357.35 373.81
Increase Decrease in Cost
-7.15 3.48 8.04 -2.66 4.81
Other Manufacturing Expense
11.16 12.78 14.37 18.5 23.57
Employee Cost
46.02 52.33 61.33 71.5 80.49
Miscellaneous Expenses
96.37 85.98 98.94 123.31 151.75
Operating Profit
53.78 62.11 60.2 59.59 63.54
Other Income
19.63 8.31 10.32 11.58 20.96
Depreciation
35.28 33.53 32.3 26.44 22.51
Interest
13.02 0.48 0.29 0.09 0.07
Profit before tax and exceptio..
25.11 36.41 37.93 44.64 61.91
Exceptional Items
23.44 0 0 0 9.91
PBT
48.55 36.41 37.93 44.64 71.83
Provision for Taxation
-13.21 -4.32 11.36 16.15 26.51
Net Profit
61.77 40.72 26.57 28.49 45.31
NET Profit after MI
61.77 40.72 26.57 28.49 45.31
EPS
50.04 30.86 19.88 21.31 33.9
Operating Profit Margin (%)
9.81 10.38 10.84 9.91 9.81
Net Profit Margin (%)
11.27 6.8 4.78 4.74 6.99

Venus Remedies Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 41.80 41.80 41.80 41.80 41.80 41.80
FII 2.20 1.90 2.20 1.30 1.10 1.20
Public 1.10 0.70 0.20 0.00 0.00 0.10
Others 54.90 55.60 55.80 56.90 57.10 56.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: